First Horizon To Promote Fortamet, Altroprev With 100-Rep Sales Force
This article was originally published in The Pink Sheet Daily
Executive Summary
Andrx divests extended-release metformin and extended-release lovastatin to First Horizon for upfront payment of $50 mil. First Horizon's promotional efforts will focus on growing Fortamet and stabilizing Altoprev's declining market share.